Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
2006-11-28
pubmed:abstractText
The monoclonal antibody 2G2 has been used extensively for detection and quantification of structural changes of human rhinovirus serotype 2 during infection. It recognizes exclusively A and B subviral particles, not native virus. We have elucidated the basis of this selectivity by determining the footprint of 2G2. Since viral escape mutants obviously cannot be obtained, the structures of complexes between Fab fragments of 2G2 and 80S subviral B particles were determined by cryoelectron microscopy. The footprint of the antibody corresponds to the capsid region that we predicted would undergo the most dramatic changes upon RNA release.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-10069951, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-10601662, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-10903863, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-11101504, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-12191477, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-12414964, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-12692238, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-12692239, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-12857919, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-14581535, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-15064754, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-15769470, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-15919927, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-163526, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-16732623, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-183023, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-3033893, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-4126195, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-4333543, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-4335940, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-4348300, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-4359954, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-4372319, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-8189509, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-9445036, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-9707418, http://linkedlifedata.com/resource/pubmed/commentcorrection/17005641-9811698
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
12398-401
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Nonneutralizing human rhinovirus serotype 2-specific monoclonal antibody 2G2 attaches to the region that undergoes the most dramatic changes upon release of the viral RNA.
pubmed:affiliation
Institut de Biologie Structurale Jean-Pierre Ebel, UMR 5057, CEA-CNRS-UJF, 41 rue Jules Horowitz, 38027 Grenoble, France. hewat@ibs.fr
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't